Drug and Therapeutics Bulletin defends its stance over donepezilBMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7137.1092a (Published 04 April 1998) Cite this as: BMJ 1998;316:1092
- Joe Collier, Editor, Drug and Therapeutics Bulletin
- Consumers' Association, London NW1 4DF
EDITOR—Wilkinson et al criticise a review of donepezil published in Drug and Therapeutics Bulletin and question the basis for our conclusion. 1 2 The position we took was the result of much deliberation, in accordance with our normal practice.3 A detailed review of the literature makes up a large part of the preparation of articles in Drug and Therapeutics Bulletin.3 Ultimately, conclusions are based on our interpretation of such data, coupled …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial